These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1494906)

  • 1. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal.
    Xia Y; Goebel DJ; Kapatos G; Bannon MJ
    J Neurochem; 1992 Sep; 59(3):1179-82. PubMed ID: 1494906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of dopamine transporter mRNA in the rat brain: mapping, effects of "binge" cocaine administration and withdrawal.
    Maggos CE; Spangler R; Zhou Y; Schlussman SD; Ho A; Kreek MJ
    Synapse; 1997 May; 26(1):55-61. PubMed ID: 9097405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine self-administration in rats differentially alters mRNA levels of the monoamine transporters and striatal neuropeptides.
    Arroyo M; Baker WA; Everitt BJ
    Brain Res Mol Brain Res; 2000 Nov; 83(1-2):107-20. PubMed ID: 11072100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.
    Bannon MJ; Poosch MS; Xia Y; Goebel DJ; Cassin B; Kapatos G
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7095-9. PubMed ID: 1353885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
    Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
    J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
    Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F
    Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration.
    Cerruti C; Pilotte NS; Uhl G; Kuhar MJ
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):132-8. PubMed ID: 8015373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration.
    Burchett SA; Bannon MJ
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):95-102. PubMed ID: 9387868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration.
    Meiergerd SM; Hooks SM; Schenk JO
    J Neurochem; 1994 Oct; 63(4):1277-81. PubMed ID: 7931279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the cocaine-sensitive bovine dopamine transporter.
    Usdin TB; Mezey E; Chen C; Brownstein MJ; Hoffman BJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11168-71. PubMed ID: 1722321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum.
    Kimmel HL; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):15-21. PubMed ID: 12490570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
    Van Kampen JM; McGeer EG; Stoessl AJ
    Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
    Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
    Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter mRNA in autopsy studies of chronic cocaine users.
    Chen L; Segal DM; Moraes CT; Mash DC
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):181-5. PubMed ID: 10581411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens.
    Sharpe LG; Pilotte NS; Mitchell WM; De Souza EB
    Eur J Pharmacol; 1991 Oct; 203(1):141-4. PubMed ID: 1797552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat.
    Letchworth SR; Daunais JB; Hedgecock AA; Porrino LJ
    Brain Res; 1997 Mar; 750(1-2):214-22. PubMed ID: 9098547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter mRNA: dense expression in ventral midbrain neurons.
    Shimada S; Kitayama S; Walther D; Uhl G
    Brain Res Mol Brain Res; 1992 May; 13(4):359-62. PubMed ID: 1352613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones.
    Augood SJ; Westmore K; McKenna PJ; Emson PC
    Brain Res Mol Brain Res; 1993 Dec; 20(4):328-34. PubMed ID: 7906851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a human cocaine-sensitive dopamine transporter in Xenopus laevis oocytes.
    Bannon MJ; Xue CH; Shibata K; Dragovic LJ; Kapatos G
    J Neurochem; 1990 Feb; 54(2):706-8. PubMed ID: 2137162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain.
    Cerruti C; Walther DM; Kuhar MJ; Uhl GR
    Brain Res Mol Brain Res; 1993 Apr; 18(1-2):181-6. PubMed ID: 8479287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.